Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Cell Dyscrasias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Not applicableActive Not RecruitingNCT02671448
What this trial is testing

Pilot Trial of Homebound Stem Cell Transplantation

Who this might be right for
Plasma Cell Dyscrasia
Memorial Sloan Kettering Cancer Center 83
Testing effectiveness (Phase 2)Looking for participantsNCT04879043
What this trial is testing

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Disorder
Heidelberg Pharma AG 78
Not applicableEnrolling By InvitationNCT04210791
What this trial is testing

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

Who this might be right for
AL AmyloidosisPlasma Cell Dyscrasia
Nanjing University School of Medicine 500
Testing effectiveness (Phase 2)Ended earlyNCT00579111
What this trial is testing

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Who this might be right for
Myelodysplastic and Myeloproliferative DisordersAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
Baylor College of Medicine 4
Not applicableLooking for participantsNCT06870760
What this trial is testing

Pre-malignant States to Hematologic Malignancies in Firefighters

Who this might be right for
Clonal Hematopoiesis of Indeterminate PotentialMonoclonal GammopathyNon Hodgkin Lymphoma+3 more
Wake Forest University Health Sciences 300
Large-scale testing (Phase 3)Active Not RecruitingNCT04504825
What this trial is testing

Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

Who this might be right for
AL Amyloidosis
Alexion Pharmaceuticals, Inc. 125
Not applicableUnknownNCT03405571
What this trial is testing

Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.

Who this might be right for
Multiple MyelomaVenous Thromboembolism
University of Athens 800
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Testing effectiveness (Phase 2)Study completedNCT01816620
What this trial is testing

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

Who this might be right for
POEMS Syndrome
Peking Union Medical College Hospital 41
Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Not applicableLooking for participantsNCT03616483
What this trial is testing

The Indiana Myeloma Registry

Who this might be right for
Plasma Cell Dyscrasias
Indiana University 2,500
Testing effectiveness (Phase 2)Study completedNCT02041325
What this trial is testing

Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias

Who this might be right for
Plasma Cell Disorder
Boston VA Research Institute, Inc. 38
Not applicableNot Yet RecruitingNCT06330896
What this trial is testing

Disease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalities From Fluorescence In Situ Hybridization and Next Generation Sequencing

Who this might be right for
Plasma Cell Disorder
Siriraj Hospital 498
Not applicableLooking for participantsNCT01351545
What this trial is testing

Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Who this might be right for
Hematologic MalignanciesInherited Disorders of MetabolismInherited Abnormalities of Platelets+14 more
Center for International Blood and Marrow Transplant Research 99,999
Early research (Phase 1)Study completedNCT01248923
What this trial is testing

ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma, Plasma Cell Leukemia
Array Biopharma, now a wholly owned subsidiary of Pfizer 55
Not applicableStudy completedNCT01186224
What this trial is testing

Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC)

Who this might be right for
Multiple MyelomaPlasma Cell DyscrasiaLymphoma+1 more
University of Liverpool 60
Not applicableStudy completedNCT02274519
What this trial is testing

Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Disorder
Mayo Clinic 29